Invasive Pneumococcal Diseases in Korean Adults After the Introduction of Pneumococcal Vaccine into the National Immunization Program

키워드

참고문헌 (60)

1. Drijkoningen JJ, "Pneumococcal infection in adults : burden of disease", Clin Microbiol Infect, 20(Suppl 5), pp.45~51 (2014)
2. Song JY, "Clinical and economic burden of invasive pneumococcal disease in adults : a multicenter hospital-based study", BMC Infect Dis, 13, pp.202~ (2013)
3. Heo JY, "Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults : Catchment population-based analysis", PLoS One, 13, pp.e0194598~ (2018)
4. Kim JH, "Adult invasive pneumococcal disease in the Republic of Korea : risk medical conditions and mortality stratified by age group", Int J Infect Dis, 74, pp.136~144 (2018)
5. Yoon JG, "Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era : Serotype-dependent difference in ceftriaxone susceptibility", Vaccine, 40, pp.2258~2265 (2022)
6. Lee S, "Changes in serotype prevalence and antimicrobial resistance among invasive Streptococcus pneumoniae isolates in Korea, 1996-2008", J Med Microbiol, 62, pp.1204~1210 (2013)
7. 박동철, "Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016", Annals of Laboratory Medicine, 39(6), pp.537~544 (2019), 대한진단검사의학회[DOI]
8. Kim Gyu Ri, "Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine", Annals of Laboratory Medicine, 43(1), pp.45~54 (2023), 대한진단검사의학회[DOI]
9. Blasi F, "Understanding the burden of pneumococcal disease in adults", Clin Microbiol Infect, 18(Suppl 5), pp.7~14 (2012)
10. 최영준, "The Changing Epidemiology of Childhood Pneumococcal Disease in Korea", Infection and Chemotherapy, 45(2), pp.145~148 (2013), 대한감염학회
11. "National childhood vaccination coverage among children aged 1-3 and 6years in Korea" (2022)[URL]
12. Choi Won Suk, "Adult Immunization Policy in Korea", Infection and Chemotherapy, 55(3), pp.317~321 (2023), 대한감염학회[DOI]
13. "Annual report on the notified infectious diseases in Korea, 2022"[URL]
14. 김영근, "Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease", Infection and Chemotherapy, 48(4), pp.257~266 (2016), 대한감염학회
15. Kim SH, "Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries : an Asian network for surveillance of resistant pathogens(ANSORP)study", Antimicrob Agents Chemother, 56, pp.1418~1426 (2012)
16. 유정래, "Changes in Serotype of Streptococcus pneumoniae After the Introduction of the 13-Valent Pneumococcal Vaccine in a Homogenous Population on Jeju Island", Infection and Chemotherapy, 51(1), pp.67~72 (2019), 대한감염학회[DOI]
17. Fitzgerald D, "Invasive pneumococcal and meningococcal disease", Infect Dis Clin North Am, 33, pp.1125~1141 (2019)
18. Weinberger DM, "Association of serotype with risk of death due to pneumococcal pneumonia : a meta-analysis", Clin Infect Dis, 51, pp.692~699 (2010)
19. Brueggemann AB, "Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clonespecific differences in invasive disease potential", J Infect Dis, 187, pp.1424~1432 (2003)
20. Fenoll A, "Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain : a 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study", Vaccine, 36, pp.7993~8000 (2018)
21. Musher DM, "Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia : association with nasopharyngeal colonization", Clin Infect Dis, 24, pp.441~446 (1997)
22. Romero-Steiner S, "Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity", Clin Infect Dis, 29, pp.281~288 (1999)
23. Lee H, "The effect of age on the response to the pneumococcal polysaccharide vaccine", BMC Infect Dis, 10, pp.60~ (2010)
24. Zhang D, "Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases : an observational database study", BMC Infect Dis, 18, pp.436~ (2018)
25. Kyaw MH, "The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults", J Infect Dis, 192, pp.377~386 (2005)
26. Baxter R, "Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults", Vaccine, 34, pp.4293~4297 (2016)
27. Nuorti JP, "Cigarette smoking and invasive pneumococcal disease", N Engl J Med, 342, pp.681~689 (2000)
28. Sangil A, "Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed", J Infect, 71, pp.422~427 (2015)
29. Torres A, "Risk factors for community-acquired pneumonia in adults in Europe : a literature review", Thorax, 68, pp.1057~1065 (2013)
30. Rákóczi É, "Pneumococcal vaccination in autoimmune rheumatic diseases", RMD Open, 3, pp.e000484~ (2017)
31. 서유빈, "The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease", Infection and Chemotherapy, 52(2), pp.252~280 (2020), 대한감염학회[DOI]
32. van Aalst M, "The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination : A systematic review and meta-analysis", Vaccine, 36, pp.5832~5845 (2018)
33. 성혜, "Assessment of Disease Burden and Immunization Rates for Vaccine-Preventable Diseases in People Living with HIV: The Korea HIV", AIDS Cohort Study, 2023, pp.55(4), 441~450[DOI]
34. Holdsworth RJ, "Postsplenectomy sepsis and its mortality rate : actual versus perceived risks", Br J Surg, 78, pp.1031~1038 (1991)
35. Theilacker C, "Overwhelming postsplenectomy infection : a prospective multicenter cohort study", Clin Infect Dis, 62, pp.871~878 (2016)
36. Kang JM, "Risk of invasive pneumococcal disease in patients with asplenia", hyposplenism : a nationwide population-based study in Korea, 2009-2018, 2020, pp.98, 486~493
37. Weinberger DM, "Pneumococcal disease seasonality : incidence, severity and the role of influenza activity", Eur Respir J, 43, pp.833~841 (2014)
38. Chen H, "Prognostic factors for mortality in invasive pneumococcal disease in adult : a system review and meta-analysis", Sci Rep, 11, pp.11865~ (2021)
39. Bullen B, "Letter : Bacteraemia caused by tetracycline-resistant Pneumococcus type 1", Lancet, 1, pp.466~467 (1975)
40. Kim SH, "Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia : emergence of drug-resistant non-vaccine serotypes", Vaccine, 38, pp.6065~6073 (2020)
41. Appelbaum PC, "World-wide development of antibiotic resistance in pneumococci", Eur J Clin Microbiol, 6, pp.367~377 (1987)
42. Torumkuney D, "Results from the survey of antibiotic resistance(SOAR)2012-14 in Thailand, India, South Korea and Singapore", J Antimicrob Chemother, 71(Suppl 1), pp.i3~19 (2016)
43. Ho PL, "Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children", Vaccine, 22, pp.3334~3339 (2004)
44. Demczuk WHB, "Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016", Vaccine, 36, pp.4701~4707 (2018)
45. Waight PA, "Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction : an observational cohort study", Lancet Infect Dis, 15, pp.535~543 (2015)
46. Ruhe JJ, "High-level penicillinnonsusceptible Streptococcus pneumoniae bacteremia : identification of a low-risk subgroup", Clin Infect Dis, 38, pp.508~514 (2004)
47. Choi MJ, "Spread of ceftriaxone non-susceptible pneumococci in South Korea : Long-term care facilities as a potential reservoir", PLoS One, 14, pp.e0210520~ (2019)
48. Càmara J, "A historical perspective of MDR invasive pneumococcal disease in Spanish adults", J Antimicrob Chemother, 76, pp.507~515 (2021)
49. Kolozsvári LR, "Patient-related factors, antibiotic prescribing and antimicrobial resistance of the commensal Staphylococcus aureus and Streptococcus pneumoniae in a healthy population-Hungarian results of the APRES study", BMC Infect Dis, 19, pp.253~ (2019)
50. Yu VL, "An international prospective study of pneumococcal bacteremia : correlation with in vitro resistance, antibiotics administered, and clinical outcome", Clin Infect Dis, 37, pp.230~237 (2003)
51. Pallares R, "The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections", Am J Med, 113, pp.120~126 (2002)
52. Metlay JP, "Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia", Clin Infect Dis, 30, pp.520~528 (2000)
53. Feikin DR, "Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997", Am J Public Health, 90, pp.223~229 (2000)
54. Kang CI, "Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases : a post hoc analysis of a prospective cohort", Infection, 41, pp.151~157 (2013)
55. Li Y, "Penicillin-binding protein transpeptidase signatures for tracking and predicting β-lactam resistance levels in Streptococcus pneumoniae", MBio, 7, pp.e00756-16~ (2016)
56. Lee HY, "Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan", J Microbiol Immunol Infect, 51, pp.500~509 (2018)
57. Kawaguchiya M, "Clonal lineages and antimicrobial resistance of nonencapsulated Streptococcus pneumoniae in the postpneumococcal conjugate vaccine era in Japan", Int J Infect Dis, 105, pp.695~701 (2021)
58. Hanada S, "Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease", PLoS One, 11, pp.e0147877~ (2016)
59. Olarte L, "Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States", J Clin Microbiol, 55, pp.724~734 (2017)
60. 이미숙, "Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia", Infection and Chemotherapy, 50(2), pp.160~198 (2018), 대한감염학회

관련 논문AI추천